ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+14.09%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$730M
AUM Growth
+$730M
(+5.3%)
Cap. Flow
-$1.39M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
35
New
7
Increased
7
Reduced
6
Closed
12
Top Buys
| 1 |
Universal Health Services
UHS
|
$74.2M |
| 2 |
Exact Sciences
EXAS
|
$47M |
| 3 |
Boston Scientific
BSX
|
$46M |
| 4 |
United Therapeutics
UTHR
|
$44.2M |
| 5 |
Icon
ICLR
|
$40M |
Top Sells
| 1 |
Sanofi
SNY
|
$64.2M |
| 2 |
UnitedHealth
UNH
|
$37.8M |
| 3 |
Gilead Sciences
GILD
|
$34.8M |
| 4 |
Evolent Health
EVH
|
$32.5M |
| 5 |
Charles River Laboratories
CRL
|
$26.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Idexx Laboratories
IDXX
$50.7B
| – | – |
-50,000
| Closed | -$25M |
|
27
Legend Biotech
LEGN
$6.64B
| – | – |
-500,000
| Closed | -$24.1M |
|
28
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
0
| – | – |
|
29
Schrodinger
SDGR
$1.42B
| – | – |
-595,697
| Closed | -$15.7M |
|
|
30
Sanofi
SNY
$122B
| – | – |
-1,179,736
| Closed | -$64.2M |
|
31
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-160,000
| Closed | -$22.1M |
|
32
Stereotaxis
STXS
$246M
| – | – |
-1,832,577
| Closed | -$3.74M |
|
|
TSVT
33
DELISTED
2seventy bio
TSVT
| – | – |
-868,939
| Closed | -$8.86M |
|
|
34
UnitedHealth
UNH
$279B
| – | – |
-80,000
| Closed | -$37.8M |
|
|
CUTR
35
DELISTED
Cutera, Inc.
CUTR
| – | – |
-600,000
| Closed | -$14.2M |
|